EPA:ERF - Euronext Paris - Matif - FR0014000MR3 - Common Stock - Currency: EUR
EPA:ERF (3/7/2025, 7:00:00 PM)
51.36
-0.36 (-0.7%)
The current stock price of ERF.PA is 51.36 EUR. In the past month the price increased by 0.71%. In the past year, price decreased by -8.19%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.07 | 182.78B | ||
DAP.DE | DANAHER CORP | 28.32 | 139.67B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 55.77 | 19.00B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 55.17 | 18.79B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 46.36 | 17.15B | ||
SRT.DE | SARTORIUS AG | 37.17 | 13.75B | ||
ILU.DE | ILLUMINA INC | 34.19 | 12.24B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 28.63 | 9.95B | ||
QIA.DE | QIAGEN N.V. | 18.07 | 7.89B | ||
1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 25.09 | 3.74B | ||
GXI.DE | GERRESHEIMER AG | 25.2 | 2.77B | ||
EVT.DE | EVOTEC SE | N/A | 2.34B |
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.
EUROFINS SCIENTIFIC
23 Val Fleuri
Luxembourg LU
Employees: 61798
Company Website: https://www.eurofins.com/
Investor Relations: https://www.eurofins.com/investors
Phone: 35226185320
The current stock price of ERF.PA is 51.36 EUR. The price decreased by -0.7% in the last trading session.
The exchange symbol of EUROFINS SCIENTIFIC is ERF and it is listed on the Euronext Paris - Matif exchange.
ERF.PA stock is listed on the Euronext Paris - Matif exchange.
20 analysts have analysed ERF.PA and the average price target is 58.89 EUR. This implies a price increase of 14.66% is expected in the next year compared to the current price of 51.36. Check the EUROFINS SCIENTIFIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EUROFINS SCIENTIFIC (ERF.PA) has a market capitalization of 9.91B EUR. This makes ERF.PA a Mid Cap stock.
EUROFINS SCIENTIFIC (ERF.PA) currently has 61798 employees.
EUROFINS SCIENTIFIC (ERF.PA) has a support level at 49.73 and a resistance level at 52.52. Check the full technical report for a detailed analysis of ERF.PA support and resistance levels.
The Revenue of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 7.56% in the next year. Check the estimates tab for more information on the ERF.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EUROFINS SCIENTIFIC (ERF.PA) has a dividend yield of 1.16%. The yearly dividend amount is currently 0.52. Check the full fundamental report for a detailed analysis of ERF.PA dividend history, reliability and sustainability.
EUROFINS SCIENTIFIC (ERF.PA) will report earnings on 2025-04-23.
The PE ratio for EUROFINS SCIENTIFIC (ERF.PA) is 28.53. This is based on the reported non-GAAP earnings per share of 1.8 and the current share price of 51.36 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ERF.PA.
ChartMill assigns a technical rating of 5 / 10 to ERF.PA. When comparing the yearly performance of all stocks, ERF.PA turns out to be only a medium performer in the overall market: it outperformed 41.55% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA. Both the profitability and the financial health of ERF.PA get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months ERF.PA reported a non-GAAP Earnings per Share(EPS) of 1.8. The EPS increased by 40.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 5.08% | ||
ROA | 3.24% | ||
ROE | 6.61% | ||
Debt/Equity | 0.59 |
ChartMill assigns a Buy % Consensus number of 67% to ERF.PA. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of 14.09% and a revenue growth 7.56% for ERF.PA